Each row is a drug, each column a cancer subtype. Cells show the strongest known association for that drug in that cancer: approved clinical trial or blank. The repositionable flag means the drug appears as a synthetic-lethal repositioning candidate in cansar; it’s gene-level, not cancer-level.
| Drug | Target | Relationship | GBM | LUAD | SCLC | LUSC | OAC | OSCC | PDAC | Reposition | #cancers |
|---|---|---|---|---|---|---|---|---|---|---|---|
| alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel | DHFR | Direct | 2 | ||||||||
| avelumab, lorlatanib, talazoparib, pemetrexed, axitinib, cmp 001, utomilumab, pf04518600 | DHFR | Direct | 2 | ||||||||
| biospecimen collection, computed tomography, pemetrexed | DHFR | Direct | 2 | ||||||||
| cisplatin, pemetrexed, gemcitabine, carboplatin, certolizumab, nivolumab | DHFR | Direct | 2 | ||||||||
| inbrx-109, carboplatin, cisplatin, pemetrexed, 5-fluorouracil, irinotecan, temozolomide | DHFR | Direct | 2 | ||||||||
| ioa-244, avelumab injection, pemetrexed, cisplatin, ruxolitinib | DHFR | Direct | 2 | ||||||||
| laboratory biomarker analysis, oxaliplatin, pralatrexate | DHFR | Direct | 2 | ||||||||
| ly4066434., cetuximab, nab paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, 5fluorouracil, carboplatin, cisplatin, pemetrexed, pembrolizumab | DHFR | Direct | 2 | ||||||||
| mk-0482, pembrolizumab, paclitaxel, nab-paclitaxel, gemcitabine, carboplatin, pemetrexed | DHFR | Direct | 2 | ||||||||
| mk-4830, pembrolizumab, carboplatin, pemetrexed, lenvatinib, paclitaxel, cisplatin, mk-4830a | DHFR | Direct | 2 | ||||||||
| ociperlimab, tislelizumab, pemetrexed, paclitaxel, nab paclitaxel, carboplatin, cisplatin, etoposide, 5fluorouracil, oxaliplatin, capecitabine | DHFR | Direct | 2 | ||||||||
| pemetrexed, bevacizumab | DHFR | Direct | 2 | ||||||||
| pralatrexate, docetaxel, fludeoxyglucose f 18, positron emission tomography | DHFR | Direct | 2 | ||||||||
| sar444881, pembrolizumab, cetuximab, carboplatin, pemetrexed | DHFR | Direct | 2 | ||||||||
| tislelizumab, pemetrexed | DHFR | Direct | 2 | ||||||||
| whole brain low dose radiotherapy, pemetrexed, sintilimab, chemotherapy | DHFR | Direct | 2 | ||||||||
| andecaliximab, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed, leucovorin, oxaliplatin, 5-fu, bevacizumab, irinotecan, paclitaxel | DHFR | Direct | 1 | ||||||||
| can04, cisplatin, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed | DHFR | Direct | 1 | ||||||||
| certolizumab, cisplatin, pemetrexed | DHFR | Direct | 1 | ||||||||
| cisplatin, methotrexate, vinorelbine ditartrate, adjuvant therapy, conventional surgery, neoadjuvant therapy, 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy | DHFR | Direct | 1 | ||||||||
| cryoablation, pembrolizumab, pemetrexed, carboplatin | DHFR | Direct | 1 | ||||||||
| epacadostat, pembrolizumab, oxaliplatin, leucovorin, 5-fluorouracil, gemcitabine, nab-paclitaxel, carboplatin, paclitaxel, pemetrexed, cyclophosphamide, carboplatin, cisplatin, 5-fluorouracil, investigator's choice of platinum agent | DHFR | Direct | 1 | ||||||||
| erlotinib, pemetrexed, cisplatin, erlotinib | DHFR | Direct | 1 | ||||||||
| farletuzumab, placebo, carboplatin, paclitaxel, pemetrexed, cisplatin | DHFR | Direct | 1 | ||||||||
| gen1042, pembrolizumab, cisplatin, carboplatin, 5-fu, gemcitabine, nab paclitaxel, pemetrexed, paclitaxel | DHFR | Direct | 1 | ||||||||
| leucovorin calcium, methotrexate | DHFR | Direct | 1 | ||||||||
| methotrexate, pharmacological study | DHFR | Direct | 1 | ||||||||
| mopp regimen, leucovorin calcium, mechlorethamine hydrochloride, methotrexate, prednisone, procarbazine hydrochloride, vincristine sulfate, conventional surgery | DHFR | Direct | 1 | ||||||||
| paclitaxel, pemetrexed, 5fluorouracil, carboplatin, pembrolizumab | DHFR | Direct | 1 | ||||||||
| pemetrexed | DHFR | Direct | yes | 1 | |||||||
| pemetrexed, cetuximab, cisplatin, folic acid, vitamin b12 | DHFR | Direct | 1 | ||||||||
| pemetrexed, cisplatin | DHFR | Direct | 1 | ||||||||
| pf-07934040, gemcitabine, nab-paclitaxel, cetuximab, fluorouracil, oxaliplatin, leucovorin, bevacizumab, pembrolizumab, pemetrexed, cisplatin, paclitaxel, carboplatin | DHFR | Direct | 1 | ||||||||
| pf-07985045, gemcitabine, nab-paclitaxel, cetuximab, fluorouracil, oxaliplatin, leucovorin, bevacizumab, pembrolizumab, sasanlimab, pemetrexed, cisplatin, paclitaxel, carboplatin, pf-07284892 | DHFR | Direct | 1 | ||||||||
| tacrolimus, methotrexate, sirolimus | DHFR | Direct | 1 | ||||||||
| treosulfan, fludarabine phosphate, tacrolimus, methotrexate, lapine t-lymphocyte immune globulin, peripheral blood stem cell transplantation, allogeneic bone marrow transplantation, quality-of-life assessment, echocardiography, multigated acquisition scan, bone marrow biopsy, bone marrow aspiration, biospecimen collection, x-ray imaging, computed tomography | DHFR | Direct | 1 | ||||||||
| methotrexate | DHFR | Direct | yes | 0 | |||||||
| methotrexate sodium | DHFR | Direct | yes | 0 | |||||||
| pemetrexed disodium | DHFR | Direct | yes | 0 | |||||||
| pralatrexate | DHFR | Direct | yes | 0 | |||||||
| unnamed compound | DHFR | Direct | yes | 0 | |||||||
| adagrasib | KRAS | SSL via KRAS | yes | 2 | |||||||
| afatinib | EGFR | SSL via EGFR | yes | 2 | |||||||
| dacomitinib | EGFR | SSL via EGFR | yes | 2 | |||||||
| erlotinib | EGFR | SSL via EGFR | yes | 2 | |||||||
| gefitinib | EGFR | SSL via EGFR | yes | 2 | |||||||
| sotorasib | KRAS | SSL via KRAS | yes | 2 | |||||||
| lazertinib and amivantamab | EGFR | SSL via EGFR | 1 | ||||||||
| osimertinib | EGFR | SSL via EGFR | yes | 1 | |||||||
| ab122, ab122, tas-116, ab122, tas-116, ab122, tas-116, ab122, tas-120, ab122, tas-115, ab122, tas-115, ab122, tas-102, ramucirumab, ab122, tas-102, bevacizumab, ab122, ab122, tas-120, fluorouracil, cisplatin, ab122, tas-120, ab154, ab122, tas-120, fluorouracil, carboplatin, cisplatin, ab122, tas-120, ab154, ab122, tas-120, carboplatin, nab-paclitaxel, ab122, tas-120, cisplatin, gemcitabine, ab122, tas-120, nab-paclitaxel, gemcitabine | TYMS | SSL via TYMS | 3 | ||||||||
| adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib | WEE1 | SSL via WEE1 | 3 | ||||||||
| capecitabine, cisplatin | TYMS | SSL via TYMS | 3 | ||||||||
| gemcitabine | TYMS | SSL via TYMS | 3 | ||||||||
| srf617, gemcitabine, albumin-bound paclitaxel, pembrolizumab | TYMS | SSL via TYMS | 3 | ||||||||
| 5-fu, atezolizumab, bevacizumab, gemcitabine, leucovorin, nab-paclitaxel, oxaliplatin, capecitabine, cisplatin | TYMS | SSL via TYMS | 2 | ||||||||
| ab598, zimberelimab, fluorouracil, leucovorin, oxaliplatin | TYMS | SSL via TYMS | 2 | ||||||||
| adavosertib, radiation therapy | WEE1 | SSL via WEE1 | 2 | ||||||||
| alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel | TYMS | SSL via TYMS | 2 | ||||||||
| asp2138, pembrolizumab, oxaliplatin, leucovorin, fluorouracil, ramucirumab, paclitaxel, irinotecan | TYMS | SSL via TYMS | 2 | ||||||||
| asp3082, cetuximab, leucovorin, oxaplatin, fluorouracil, irinotecan, nanoparticle albumin-bound-paclitaxel, gemcitabine | TYMS | SSL via TYMS | 2 | ||||||||
| avelumab, lorlatanib, talazoparib, pemetrexed, axitinib, cmp 001, utomilumab, pf04518600 | TYMS | SSL via TYMS | 2 | ||||||||
| bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment | TYMS | SSL via TYMS | 2 | ||||||||
| bevacizumab, oxaliplatin, leucovorin calcium, fluorouracil, therapeutic conventional surgery, laboratory biomarker analysis | TYMS | SSL via TYMS | 2 | ||||||||
| biospecimen collection, computed tomography, devimistat, fluorouracil, gemcitabine hydrochloride, hydroxychloroquine, magnetic resonance imaging | TYMS | SSL via TYMS | 2 | ||||||||
| biospecimen collection, computed tomography, pemetrexed | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine | TYMS | SSL via TYMS | yes | 2 | |||||||
| capecitabine, carboplatin, epirubicin hydrochloride | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine, docetaxel | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine, irinotecan hydrochloride | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine, oxaliplatin | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine, oxaliplatin, gene expression analysis, microarray analysis, reverse transcriptase-polymerase chain reaction, adjuvant therapy, biopsy, conventional surgery, neoadjuvant therapy, quality-of-life assessment, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| capecitabine, temozolomide | TYMS | SSL via TYMS | 2 | ||||||||
| carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cetuximab, cisplatin, fluorouracil, conventional surgery | TYMS | SSL via TYMS | 2 | ||||||||
| chemotherapy, cisplatin, fluorouracil, low-let electron therapy, low-let photon therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, fluorouracil, conventional surgery, neoadjuvant therapy, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, fluorouracil, iressa, conventional surgery, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, fluorouracil, paclitaxel, conventional surgery, neoadjuvant therapy, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, fluorouracil, paclitaxel, surgical procedure, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, fluorouracil, surgical procedure, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| cisplatin, pemetrexed, gemcitabine, carboplatin, certolizumab, nivolumab | TYMS | SSL via TYMS | 2 | ||||||||
| durvalumab, tremelimumab, oxaliplatin, capecitabine, radiotherapy, paclitaxel, carboplatin, 5-fluorouracil (5-fu), leucovorin, docetaxel | TYMS | SSL via TYMS | 2 | ||||||||
| erlotinib hydrochloride, oxaliplatin, fluorouracil, radiation therapy, conventional surgery, immunohistochemistry staining method, positron emission tomography, computed tomography, laboratory biomarker analysis, gene expression analysis, fludeoxyglucose f 18 | TYMS | SSL via TYMS | 2 | ||||||||
| filgrastim, cisplatin, fluorouracil, paclitaxel, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| filgrastim, pegfilgrastim, cisplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| fluorouracil, gemcitabine hydrochloride, leucovorin calcium | TYMS | SSL via TYMS | 2 | ||||||||
| fluorouracil, irinotecan hydrochloride, leucovorin calcium, pharmacogenomic studies, pharmacological study | TYMS | SSL via TYMS | 2 | ||||||||
| fluorouracil, irinotecan hydrochloride, leucovorin calcium, vorinostat, pharmacological study | HDAC2 | SSL via HDAC2 | 2 | ||||||||
| fluorouracil, irinotecan hydrochloride, leucovorin calcium, vorinostat, pharmacological study | TYMS | SSL via TYMS | 2 | ||||||||
| fluorouracil, oxaliplatin, conventional surgery, radiation therapy | TYMS | SSL via TYMS | 2 | ||||||||
| inbrx-109, carboplatin, cisplatin, pemetrexed, 5-fluorouracil, irinotecan, temozolomide | TYMS | SSL via TYMS | 2 | ||||||||
| ioa-244, avelumab injection, pemetrexed, cisplatin, ruxolitinib | TYMS | SSL via TYMS | 2 | ||||||||
| irinotecan, capecitabine | TYMS | SSL via TYMS | 2 | ||||||||
| laboratory biomarker analysis, oxaliplatin, pralatrexate | TYMS | SSL via TYMS | 2 | ||||||||
| ly4066434., cetuximab, nab paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, 5fluorouracil, carboplatin, cisplatin, pemetrexed, pembrolizumab | TYMS | SSL via TYMS | 2 | ||||||||
| m6620, cisplatin, capecitabine, radiotherapy | TYMS | SSL via TYMS | 2 | ||||||||
| mk-0482, pembrolizumab, paclitaxel, nab-paclitaxel, gemcitabine, carboplatin, pemetrexed | TYMS | SSL via TYMS | 2 | ||||||||
| mk-4830, pembrolizumab, carboplatin, pemetrexed, lenvatinib, paclitaxel, cisplatin, mk-4830a | TYMS | SSL via TYMS | 2 | ||||||||
| nab-paclitaxel, gemcitabine | TYMS | SSL via TYMS | 2 | ||||||||
| ociperlimab, tislelizumab, pemetrexed, paclitaxel, nab paclitaxel, carboplatin, cisplatin, etoposide, 5fluorouracil, oxaliplatin, capecitabine | TYMS | SSL via TYMS | 2 |